Growing community of inventors

Indianapolis, IN, United States of America

Kevin Charles Fortner

Average Co-Inventor Count = 6.63

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Kevin Charles FortnerDavid Andrew Coates (2 patents)Kevin Charles FortnerSteven Marc Massey (2 patents)Kevin Charles FortnerMiles Goodman Siegel (2 patents)Kevin Charles FortnerJason Kenneth Myers (2 patents)Kevin Charles FortnerRussell Dean Stucky (1 patent)Kevin Charles FortnerDeqi Guo (1 patent)Kevin Charles FortnerQing Shi (1 patent)Kevin Charles FortnerRichard Duane Johnston (1 patent)Kevin Charles FortnerSerge Louis Boulet (1 patent)Kevin Charles FortnerSheng-Bin Peng (1 patent)Kevin Charles FortnerChong Si (1 patent)Kevin Charles FortnerAntonio Navarro (1 patent)Kevin Charles FortnerDavid Michael Hyman (1 patent)Kevin Charles FortnerDavid Michael Hyman (0 patent)Kevin Charles FortnerKevin Charles Fortner (3 patents)David Andrew CoatesDavid Andrew Coates (33 patents)Steven Marc MasseySteven Marc Massey (12 patents)Miles Goodman SiegelMiles Goodman Siegel (11 patents)Jason Kenneth MyersJason Kenneth Myers (4 patents)Russell Dean StuckyRussell Dean Stucky (23 patents)Deqi GuoDeqi Guo (20 patents)Qing ShiQing Shi (17 patents)Richard Duane JohnstonRichard Duane Johnston (12 patents)Serge Louis BouletSerge Louis Boulet (11 patents)Sheng-Bin PengSheng-Bin Peng (9 patents)Chong SiChong Si (3 patents)Antonio NavarroAntonio Navarro (2 patents)David Michael HymanDavid Michael Hyman (1 patent)David Michael HymanDavid Michael Hyman (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Eli Lilly and Company (3 from 4,442 patents)


3 patents:

1. 11731984 - KRas G12C inhibitors

2. 9708297 - CGRP receptor antagonists

3. 9637495 - CGRP receptor antagonists

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…